Bicycle Therapeutics operates as a dual-headquartered biopharmaceutical enterprise with its primary research and discovery laboratories situated in Cambridge, United Kingdom, where its proprietary bicyclic peptide technology platform was originally invented. Additionally, the company maintains its corporate and U.S. operational headquarters in Cambridge, Massachusetts, placing its executive leadership team and clinical development groups directly within major global biotechnology hubs.